Efficacy and Safety of Clobazam as Adjunctive Therapy for Pediatric Patients with Refractory Epilepsy in Xinjiang, China: A Multicenter Real-World Study

Ting Zhao, Hong-Jian Li, Hui-Lan Zhang, Lu-Hai Yu, Jing Yu, Yan Sun, Lu-Feng Cheng

Open source

DOI
10.2147/dddt.s652340
Published
2026-10
Container
Drug Design, Development and Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s652340,
  title = {Efficacy and Safety of Clobazam as Adjunctive Therapy for Pediatric Patients with Refractory Epilepsy in Xinjiang, China: A Multicenter Real-World Study},
  author = {Ting Zhao and Hong-Jian Li and Hui-Lan Zhang and Lu-Hai Yu and Jing Yu and Yan Sun and Lu-Feng Cheng},
  year = {2026},
  journal = {Drug Design, Development and Therapy},
  doi = {10.2147/dddt.s652340},
  url = {https://doi.org/10.2147/dddt.s652340}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Clobazam as Adjunctive Therapy for Pediatric Patients with Refractory Epilepsy in Xinjiang, China: A Multicenter Real-World Study
AU  - Ting Zhao
AU  - Hong-Jian Li
AU  - Hui-Lan Zhang
AU  - Lu-Hai Yu
AU  - Jing Yu
AU  - Yan Sun
AU  - Lu-Feng Cheng
PY  - 2026
JO  - Drug Design, Development and Therapy
DO  - 10.2147/dddt.s652340
UR  - https://doi.org/10.2147/dddt.s652340
ER  - 

APA

Zhao, T., Li, H., Zhang, H., Yu, L., Yu, J., Sun, Y., & Cheng, L. (2026). Efficacy and Safety of Clobazam as Adjunctive Therapy for Pediatric Patients with Refractory Epilepsy in Xinjiang, China: A Multicenter Real-World Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s652340

Source records